Women’s experiences of accessing a medical termination of pregnancy through a Queensland regional sexual health service: a qualitative study

Sexual Health ◽  
2021 ◽  
Author(s):  
Colette Cashman ◽  
Sandra G. Downing ◽  
Darren Russell
Sexual Health ◽  
2010 ◽  
Vol 7 (2) ◽  
pp. 212 ◽  
Author(s):  
Sandra Downing ◽  
Heather McNamee ◽  
Debbie Penney ◽  
Joanne Leamy ◽  
Caroline de Costa ◽  
...  

Access to abortion services is often limited in parts of regional Australia, including north Queensland. Since March 2006, the Cairns Sexual Health Service (CSHS) has provided medical termination of pregnancy (MToP) services for women up to 9 weeks gestation, using a regimen of methotrexate and misoprostol. We conducted a retrospective chart audit of all women undergoing an MToP at the CSHS between 1 March 2006 and 31 March 2009. In total, 147 medical terminations in 136 women were performed during this 3-year period. At the time of first presentation, the mean age was 27 years, 77 (57%) of the 136 women were of less than 7 weeks gestation and 86 (63%) had not had a previous termination. A successful medical termination of pregnancy was achieved in 69 of 85 (81%, 95% confidence interval (CI): 72, 88) women at less than 7 weeks gestation and in 43 of 62 (69%, 95% CI: 57, 80) women with gestation between 7 and 9 weeks. Provision of medical termination of pregnancy through sexual health services is one strategy to address access inequity in regional areas. Demand for this service in Cairns continues to rise; however, since late August 2009 MToP in Queensland is no longer available pending legal reform.


2018 ◽  
Vol 15 ◽  
pp. 23-27 ◽  
Author(s):  
Alana Hulme-Chambers ◽  
Meredith Temple-Smith ◽  
Ange Davidson ◽  
Lauren Coelli ◽  
Catherine Orr ◽  
...  

2019 ◽  
Vol 33 (2) ◽  
pp. 127-137
Author(s):  
Kittipong Saejeng ◽  
Unnop Jaisamrarn ◽  
Wanapa Naravage

Purpose The purpose of this paper is to understand women’s experiences, acceptability and outcomes of using the medical termination of pregnancy (MTP). The study is conducted at nine reproductive health and family planning clinics at university hospitals as well as regional and provincial hospitals located in Bangkok and the locations within Thailand. Design/methodology/approach This is a descriptive research recruiting healthy women with pregnancy up to 63 days since the last menstrual period (LMP) who opted for MTP during 2012–2014. Findings A total of 443 women who were referred from the reproductive health networks voluntarily participated in the study. Overall, 92.6 percent of participants had a complete abortion. No serious adverse events were found for cases using misoprostol at home or at clinic. More than 98.3 percent of the women felt satisfied or very satisfied with the method. More than 80 percent of participants thought that the side-effects of the method were as expected or less than expected. More than 95 percent of the women recommended having MTP available in Thailand. Originality/value The introduction of MTP that uses a mifepristone and misoprostol regimen (Medabon®) in pregnancies up to 63 days, since LMP demonstrates that misoprostol can be safely used by women at home or at clinic. The administration of misoprostol at home reduces the number of hospital visits, which saves time and costs for traveling from home to the facility. In addition, women have more privacy and control over their bodies by self-administering misoprostol. The MTP’s introductory results also show that MTP service provision is well integrated into reproductive health and family planning services. It is useful for stakeholders who would be involved in design and planning of health system services before the MTP is made broadly available throughout the country.


2017 ◽  
Vol 14 (1) ◽  
Author(s):  
Angela J. Dawson ◽  
Rachel Nicolls ◽  
Deborah Bateson ◽  
Anna Doab ◽  
Jane Estoesta ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document